Cullen Value Fund BMY trades
Jim Cullen
Jim Cullen Bristol-Myers Squibb Company stake
total: 75
Trades details
- Total transactions:
- 9
- New positions:
- 2
- Sold out:
- 1
- Reduced:
- 6
- Held since:
- 2024 Q3
- Held for:
- 8 quarters
- Latest activity:
- 2024 Q3
According to 2026 Q2 report, Jim Cullen holds 6,960 Bristol-Myers Squibb Company (BMY) shares with a market value of roughly $401.04K accounting for 1.25% of the overall portfolio. To date, the estimated cost basis is nearly $51.74 for "buy" trades. Cullen Value Fund first purchased BMY in 2019 Q3, initially acquiring 24,330 shares. Jim Cullen later completely sold out the position and invested in Bristol-Myers Squibb Company again in 2024 Q3. Since the initial investment in Bristol-Myers Squibb Company (BMY), Cullen Value Fund has made 8 more transactions.
When did Jim Cullen buy Bristol-Myers Squibb Company (BMY)?
Jim Cullen first invested in Bristol-Myers Squibb Company (BMY) in 2019 Q3 at the reported quarter-end price of $50.71 per share.
What's the cost basis of Cullen Value Fund's BMY stake?
The estimated cost basis for Bristol-Myers Squibb Company (BMY) stake is around $51.74 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $51.74
Jim Cullen's historical trades in Bristol-Myers Squibb Company
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q3
|
1.51%
|
6,960
|
$51.74
|
$360,110
|
new
|
+1.51%
|
|
2024 Q2
|
0.00%
|
0
|
$54.23
|
|
-100% (-10,652)
|
-2.49%
|
|
2023 Q4
|
2.47%
|
10,652
|
$51.31
|
$546,554
|
-6.41% (-729)
|
-0.18%
|
|
2023 Q3
|
3.17%
|
11,381
|
$58.04
|
$660,553
|
-6.04% (-731)
|
-0.19%
|
|
2023 Q2
|
3.49%
|
12,112
|
$63.95
|
$774,562
|
-7.77% (-1,020)
|
-0.3%
|
|
2022 Q3
|
4.48%
|
13,132
|
$71.09
|
$933,554
|
-8.93% (-1,288)
|
-0.4%
|
|
2020 Q2
|
3.74%
|
$58.80
|
-20.92% (-3,815)
|
|||
|
2019 Q4
|
3.90%
|
$64.19
|
-25.05% (-6,095)
|
|||
|
2019 Q3
|
3.17%
|
$50.71
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.